Empagliflozin Versus Placebo in Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis

Affiliations

• ¹ Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.
• ² Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
• ³ Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
• ⁴ Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.